May 14, 2026, 11:00 AM EDT
In this webinar learn how Amgen transformed its global QC Microbiology operations by implementing the Growth Direct® platform to fully automate in-process bioburden, water bioburden, and environmental monitoring testing. The webinar will share insights into the technology’s growth-based, regulatory-compliant detection capabilities and how results can be achieved within 24 hours. The presentation will walk through Amgen’s journey—from evaluating alternative technologies and building the business case to piloting and scaling the solution worldwide. Attendees will also hear how the implementation delivered measurable benefits, including faster results, increased automation, improved data integrity, and greater manufacturing capacity, demonstrating the real-world impact of digital transformation in QC Microbiology.
This webinar will provide:
- The technology and capabilities of the automated microbial contamination detection system, Growth Direct® and the advantages and benefits of growth-based, regulatory compliant contamination detection within 24hrs
- The journey including the evaluation of other technologies, identifying internal stakeholders and developing the business case and return on investment
- From pilot to global rollout, what are the important considerations for success
- Realizing the benefits of faster results, increased automation and expanded manufacturing capacity
Who should attend:
- Microbiologists
- Quality Control Directors/Managers
- Pharmaceutical Manufacturers
- Biologics Manufacturers
- Cell and Gene Therapy manufacturers and QC
Offered Free by: Rapid Micro Biosystems | American Pharmaceutical Review
See All Resources from: Rapid Micro Biosystems | American Pharmaceutical Review
